Evidence map›Paper›PMID 18941527›Full record

ArticlePloS one2008

The long march: a sample preparation technique that enhances contig length and coverage by high-throughput short-read sequencing.

Katherine Sorber, Charles Chiu, Dale Webster, Michelle Dimon, J Graham Ruby, Armin Hekele, Joseph L DeRisi

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. A Pan-HIV Strategy for Complete Genome Sequencing.Journal of clinical microbiology · 2016
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Translational research in infectious disease: current paradigms and challenges ahead.Translational research : the journal of laboratory and clinical medicine · 2012
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Katherine SorberDepartment of Biochemistry and Biophysics, University of California San Francisco, San Francisco, California, United States of America.
Charles Chiu
Dale Webster
Michelle Dimon
J Graham Ruby
Armin Hekele
Joseph L DeRisi
University of California, San Francisco · US

Funding

Howard Hughes Medical Institute
6 · The paper itself

Abstract

High-throughput short-read technologies have revolutionized DNA sequencing by drastically reducing the cost per base of sequencing information. Despite producing gigabases of sequence per run, these technologies still present obstacles in resequencing and de novo assembly applications due to biased or insufficient target sequence coverage. We present here a simple sample preparation method termed the "long march" that increases both contig lengths and target sequence coverage using high-throughput short-read technologies. By incorporating a Type IIS restriction enzyme recognition motif into the sequencing primer adapter, successive rounds of restriction enzyme cleavage and adapter ligation produce a set of nested sub-libraries from the initial amplicon library. Sequence reads from these sub-libraries are offset from each other with enough overlap to aid assembly and contig extension. We demonstrate the utility of the long march in resequencing of the Plasmodium falciparum transcriptome, where the number of genomic bases covered was increased by 39%, as well as in metagenomic analysis of a serum sample from a patient with hepatitis B virus (HBV)-related acute liver failure, where the number of HBV bases covered was increased by 42%. We also offer a theoretical optimization of the long march for de novo sequence assembly.

Indexed as

AnimalsContig MappingDeoxyribonucleases, Type II Site-SpecificHepatitis BHumansLiver FailureMethodsPlasmodium falciparumRestriction MappingRNA, MessengerSequence Analysis, DNADeoxyribonucleases, Type II Site-SpecificRNA, Messenger

Identifiers

PMID18941527
PMCPMC2566813
OpenAlexW2153668050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.